secwatch / observer
8-K filed December 30, 2025, 6:59 PM ET ticker ADVB CIK 0001941029
M&A confidence high sentiment neutral materiality 0.65

Advanced Biomed Inc. (ADVB): M&A transaction — Advanced Biomed sells Hong Kong subsidiary for $23K; moves clinical trials to Taiwan

Advanced Biomed Inc.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Advanced Biomed Inc. completed a disposition involving Wei Ha Hui for US$23,000 (closed 2025-12-23).

Action
disposition
Counterparty
Wei Ha Hui
Consideration
US$23,000
Closing
2025-12-23
Exact text from the filing
ntered into an agreement (the “ Agreement ”) with an unrelated third party, Wei Ha Hui (the “ Buyer ”), pursuant to which the Company agreed to sell 100% of the issued and outstanding shares of Advanced Biomed (HK) Limited, a Hong Kong company
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Advanced Biomed Inc. entered into Share Purchase Agreement with Wei Ha Hui valued at Purchase price of US$23,000 for 100% of Advanced Biomed (HK) Limited (effective 2025-12-23).

Action
entry
Agreement
asset purchase
Counterparty
Wei Ha Hui
Value
Purchase price of US$23,000 for 100% of Advanced Biomed (HK) Limited
Effective
2025-12-23
Exact text from the filing
On December 23, 2025, Advanced Biomed Inc. (the “ Company ”) entered into an agreement (the “ Agreement ”) with an unrelated third party, Wei Ha Hui (the “ Buyer ”), pursuant to which the Company agreed to sell 100% of the issued and outstanding shares of Advanced Biomed (HK) Limited, a Hong Kong company and a wholly owned subsidiary of the Company (the “ Hong Kong Subsidiary ”), for an aggregate purchase price of US$23,000 based on a valuation report commissioned by the Company, subject to the terms and conditions set forth in the Agreement.
View on SEC.gov

31 m&a transactions filed in the last 30 days. Browse all m&a transactions →

Advanced Biomed Inc. filing history →

Source: SEC EDGAR
accession 0001213900-25-126584
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.